COMERA LIFE SCIENCES HOLDING (CMRA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CMRA • US20037C1080

0.2227 USD
-0.02 (-8.88%)
At close: Nov 16, 2023
0.09 USD
-0.13 (-59.59%)
After Hours: 11/16/2023, 8:21:40 PM
Fundamental Rating

1

Taking everything into account, CMRA scores 1 out of 10 in our fundamental rating. CMRA was compared to 525 industry peers in the Biotechnology industry. Both the profitability and financial health of CMRA have multiple concerns. CMRA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CMRA has reported negative net income.
  • CMRA had a negative operating cash flow in the past year.
CMRA Yearly Net Income VS EBIT VS OCF VS FCFCMRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -5M -10M -15M

1.2 Ratios

  • CMRA's Return On Assets of -439.19% is on the low side compared to the rest of the industry. CMRA is outperformed by 98.00% of its industry peers.
Industry RankSector Rank
ROA -439.19%
ROE N/A
ROIC N/A
ROA(3y)-318.65%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CMRA Yearly ROA, ROE, ROICCMRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 500 -500 1K -1K

1.3 Margins

  • The Gross Margin of CMRA (74.17%) is better than 84.17% of its industry peers.
  • The Profit Margin and Operating Margin are not available for CMRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CMRA Yearly Profit, Operating, Gross MarginsCMRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 0 -500 -1K -1.5K -2K -2.5K

More info and screens

1

2. Health

2.1 Basic Checks

  • CMRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CMRA has less shares outstanding than it did 1 year ago.
  • There is no outstanding debt for CMRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CMRA Yearly Shares OutstandingCMRA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 5M 10M 15M
CMRA Yearly Total Debt VS Total AssetsCMRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2M 4M 6M

2.2 Solvency

  • CMRA has an Altman-Z score of -36.24. This is a bad value and indicates that CMRA is not financially healthy and even has some risk of bankruptcy.
  • CMRA's Altman-Z score of -36.24 is on the low side compared to the rest of the industry. CMRA is outperformed by 95.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -36.24
ROIC/WACCN/A
WACC11.01%
CMRA Yearly LT Debt VS Equity VS FCFCMRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 5M -5M

2.3 Liquidity

  • CMRA has a Current Ratio of 0.46. This is a bad value and indicates that CMRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.46, CMRA is doing worse than 95.50% of the companies in the same industry.
  • CMRA has a Quick Ratio of 0.46. This is a bad value and indicates that CMRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CMRA's Quick ratio of 0.46 is on the low side compared to the rest of the industry. CMRA is outperformed by 95.17% of its industry peers.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.46
CMRA Yearly Current Assets VS Current LiabilitesCMRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2M 4M 6M

More info and screens

1

3. Growth

3.1 Past

  • CMRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.05%, which is quite good.
  • Looking at the last year, CMRA shows a very strong growth in Revenue. The Revenue has grown by 95.59%.
EPS 1Y (TTM)13.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.93%
Revenue 1Y (TTM)95.59%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%114.72%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CMRA Yearly Revenue VS EstimatesCMRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 200K 400K 600K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CMRA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CMRA Price Earnings VS Forward Price EarningsCMRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CMRA Per share dataCMRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for CMRA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMERA LIFE SCIENCES HOLDING / CMRA FAQ

Can you provide the ChartMill fundamental rating for COMERA LIFE SCIENCES HOLDING?

ChartMill assigns a fundamental rating of 1 / 10 to CMRA.


What is the valuation status for CMRA stock?

ChartMill assigns a valuation rating of 0 / 10 to COMERA LIFE SCIENCES HOLDING (CMRA). This can be considered as Overvalued.


Can you provide the profitability details for COMERA LIFE SCIENCES HOLDING?

COMERA LIFE SCIENCES HOLDING (CMRA) has a profitability rating of 1 / 10.


How financially healthy is COMERA LIFE SCIENCES HOLDING?

The financial health rating of COMERA LIFE SCIENCES HOLDING (CMRA) is 1 / 10.